{"retracted":false,"update":{"timestamp":1441065600000,"doi":"10.1016/j.ygyno.2015.07.111","type":"err"},"doi":"10.1016/j.ygyno.2012.03.051","journal":"Gynecologic Oncology","publisher":"Elsevier BV","title":"Retraction notice to “High-mobility group protein B1 (HMGB1) is a novel biomarker for human ovarian cancer” [Gynecol. Oncol. 126 (2012) 109–117]"}
